您要查找的是不是：
- piroxicam betadex 吡罗昔康 β-环糊精复合物<消炎镇痛药>
- Objective To observe the effect of SDT with piroxicam on proliferation and apoptosis of MDA-MB-231 cells. 目的从细胞增殖和凋亡两方面观察吡罗昔康声动力效应对乳腺癌细胞MDA-MB-231的迟发抑制作用。
- The effects of perfusion concentration on nasal absorption of piroxicam was studied. 实验完毕后剖开大鼠鼻腔,发现鼻粘膜上粘附许多混悬液中的微粒。
- Objective:To investigate the suspension of inclusion compound of piroxicam nasal absorption. 目的:研究吡罗昔康包合物混悬液的鼻粘膜吸收。
- Abstract： In this paper, a new method for the determination of Piroxicam gel by the use of HPLC was reported. 摘 要： 本文提出了采用内标法，将HPLC用于吡罗昔康凝胶有效成分测定的新方法。
- The European Medicines Agency (EMEA) has recently completed a reiew of the safety of the non-steroidal anti-inflammatory drug (NSAID) piroxicam. 欧洲药品管理局（EMEA）最近完成了有关非类固醇抗炎药(NSAID)吡罗昔康的安全性评价。
- Consequently, the European Commission asked the CHMP to carry out a full assessment of the benefit-risk balance of piroxicam. 鉴于此，欧盟要求CHMP对吡罗昔康的受益与风险进行全面评价。
- The proposed method was simple, acc urate, specific and applicable to the analysis of Piroxicam gel and quality cont rol. 方法简单,准确度高，专属性强，可用于吡罗昔康凝胶样品的稳定性考察和质量控制。
- Piroxicam-Beta-Cyclodextrin is made by enwrapping medical piroxicam and medical beta-cyclodextrin in a certain inverse proportion with a unique art. 吡罗昔康倍他环糊精（又称炎痛昔康倍他环糊精），是采用独特的工艺路线，按一定的比例将医药级的倍他环糊精包合精制而成。
- Main products: Etamsylate, Bromisoval（Bromovalerylurea）, Dithranol, Benorilate, Isosorbide Mononitrate, Piroxicam, Sodium Valproate, Rubidate, Sodium Glucuronic Acid. 主要产品：酚磺乙胺、溴米索伐、地蒽酚、贝诺酯、单硝酸异山梨酯、吡罗昔康、丙戊酸钠、茜草双酯、葡萄糖醛酸钠。
- Nonselective NSAIDs include ibuprofen, etodolac and nabumetone, which may have superior GI safety than other nsNSAIDs, such as sulindac, indomethacin, piroxicam and ketorolac. 非选择性的非甾体类抗炎药，包括布洛芬、依托度酸和萘丁美酮，它们比其他非甾体类抗炎药，例如舒林酸、吲哚美辛、吡罗昔康和酮咯酸对胃肠道具有更高的安全性。
- The transdermal delivery of piroxicam was pronouncelly improved by enhancing the solubility of piroxicam with Tween 80 and forming LTRs by electroporation. 综合利用聚山梨酯80的促渗作用和电致孔时形成的水性通道,可以有效提高吡罗昔康的透皮量。
- In addition, the CHMP recommended new contraindications and strengthened warnings for piroxicam, further details of which are proided in a separate question-and-answer document. 此外，CHMP还建议了吡罗昔康新的禁忌症并强调了警告信息，其详细内容参见有关吡罗昔康评价情况问答的单独文件。
- Piroxicam is known as a non-selectie NSAID because it acts on all types of the cyclo-oxygenase enzyme, including one type that is inoled in the inflammatory process. 吡罗昔康是一种非选择性非类固醇抗炎药，作用于包括参与炎症过程的一类环氧酶在内的所有类型的环氧酶。
- Piroxicam is a NSAID, a medicine used to treat inflammation.It has been aailable on the market for many years and has been used in the treatment of many painful conditions. 吡罗昔康是一种用于治疗炎症的非类固醇抗炎药，该药物已上市多年并用于治疗多种疼痛症状。
- In addition, the CHMP recommended new contraindications and strengthened warnings for piroxicam, further details of which are provided in a separate question-and-answer document. 此外，CHMP还建议了吡罗昔康新的禁忌症并强调了警告信息，其详细内容参见有关吡罗昔康评价情况问答的单独性文件。
- The main products are Phenobarbital, Primidone, 5-Fluorouracil, 5-Flucytosine, Phenylbutazone, Piroxicam, Aminoglutethimide, Tenoxicam, Propylthiouracil, Moxonidine HCl and their intermediates and devirates. 主要产品为苯巴比妥、扑米酮、氟尿嘧啶、氟胞嘧啶、保泰松、吡罗昔康、氨鲁米特、替诺昔康、丙硫氧嘧啶、盐酸莫索尼啶及其中间体和衍生物。
- The Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded that piroxicam's benefits still outweigh its risks, but, based on safety grounds, only in certain, limited indications. 该局人用药品委员会（CHMP）的结论认为，吡罗昔康的益处仍大于其风险，但是，基于安全方面的考虑，其应用仅限于某些特定的适应症。
- In addition, the CHMP added some contraindications and strengthened warnings for piroxicam, to ensure that it is not used in patients who are at a higher risk of deeloping side effects. 此外，CHMP还增加了吡罗昔康某些禁忌症并强调了警告信息，以确保不用于那些出现副作用的高危患者。
- Study on the preparation of piroxicam films 吡罗昔康贴剂的研制
